Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 16/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4238591 | 0.91 | HCAR3 (1.00) | HCAR3MEN1KMT2A | |
| SCHEMBL6044169 | 0.84 | HCAR3 (1.00) | HCAR3MEN1KMT2A | |
| SCHEMBL5579612 | 0.83 | HCAR3 (0.70) | HCAR3MEN1KMT2A | |
| SCHEMBL6044135 | 0.82 | HCAR3 (1.00) | HCAR3MEN1KMT2A | |
| SCHEMBL321911 | 0.80 | HCAR3 (1.00) | HCAR3MEN1KMT2A | |
| SCHEMBL6044279 | 0.80 | HCAR3 (1.00) | HCAR3MEN1KMT2A | |
| SCHEMBL6044265 | 0.80 | HCAR3 (0.78) | HCAR3 | |
| Hydrochloric Acid SCHEMBL321637 | 0.79 | HCAR3 (0.97) | HCAR3MEN1KMT2A | |
| SCHEMBL6044145 | 0.79 | HCAR3 (0.68) | HCAR3MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL7428031 | 0.78 | HCAR3 (0.76) | HCAR3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060122240-A1 | Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof | ARENA PHARMACEUTICALS, INC. (US) | 2006-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060122240-A1 | Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof | GCGR, GPR119, HMGCR | HCAR3 85/4885MEN1 4692/4885KMT2A 2238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.